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A mutation network for the hemagglutinin gene (HA) of the novel type A (H1N1) influenza virus was 
constructed. Sequence homology analysis indicated that one HA sequence type from the viruses 
mainly isolated from Mexico was likely the original type in this epidemic. Based on the 658A and 1408T 
mutations in HA, the viruses evolving into this epidemic were divided into three categories, the Mexico, 
the transitional and the New York type. The three groups of viruses presented distinctive clustering 
features in their geographic distributions. 
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On April 15th and 17th 2009, the Centers for Disease 
Control and Prevention of the United States in Atlanta 
identified isolations from two children as a novel type A 
(H1N1) influenza virus[1]. Sequence homology analysis 
indicated that the novel virus was generated from a reas- 
sortment of multiple influenza viruses (from swine, 
avian and humans). Further studies found that the novel 
virus appeared in Mexico as early as on March 18, 2009. 
Some patients infected by this novel virus developed 
serious clinical syndromes and several patients died. As 
of Beijing time 14:00 May 20, 2009, 49 countries re-
ported 9830 identified cases of the novel influenza virus 
A (H1N1) infection, including 79 deaths (http://www. 
who.int/csr/don/ 2009_05_19/en/index.html).  
The genome of influenza virus A contains 8 separate  
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RNA segments, which code for different proteins which 
play certain roles in construction and duplication of the 
influenza virus. Among these proteins, hemagglutinin 
(HA) attracted much more attention. HA is located on 
the outside of the virus membrane. In hosts, the HA 
binds to sialic acids on the surface of target cells as one 
of the necessary steps for invasion. Therefore, HA is 
primarily responsible for the host range of influenza vi-
rus and immunity response of hosts to the infection[2]. 
Sequences of the HA gene from the novel influenza 
virus A (H1N1) published before May 12, 2009 were 
downloaded from database of GISAID[3]. Fifty-four full- 
length sequences with high quality passed a data clean 
procedure. The network of mutations for the sequences 
was constructed using NETWORK (version4.5.1.0, 
http://www.fluxus-technology.com/) after the multiple 
alignment was conducted using ClustalW1.83[4] (Figure 
1). Every node in the network represented a sequence 
type observed in the 54 full-length sequences. BLAST 
search in NCBI database of nucleotide sequences and 
homology analysis with an outgroup (viruses from swine) 
indicated that a node containing 4 sequences could be 
treated as an ancestral node of all the observed se-
quences[5] (Figure 1, accession number in NCBI: 
GQ117067, FJ982430, GQ149692, FJ998208). Based on 
the mutation network, the ancestral sequence type first 
appeared in the late August of 2008 (with standard de-
viation 0.24 year, that is about 3 months), giving an es-
timation of 1.83 mutations (time unit in mutation) before 
May 2009[6] and the mutation rate of the HA gene as 2.8 
bases per year[7].    
Based on the 658A and 1408T mutations in HA, the 
viruses evolving into the epidemic could be divided into 
three categories, the Mexico, the transitional and the 
New York type. The Mexico type virus was found in 
Mexico, South of the United States (such as Texas,   
 
 
Figure 1  Mutation network for HA of the novel influenza virus A (H1N1). Each node is named in sequence ID and the first three letters of the 
name of the location where the sample was isolated. When multiple sequences are presented at one node, information of one sequence will 
be used randomly to name the node. The area of each node is in proportion to the number of sequences the node represents. The ancestral 
node representing the original sequence type is marked in blue. Location and status of mutations are marked on edges in red with the original 
sequence type as a reference. Based on information of the sequences in GSAID database, 54 samples were separately collected from Ari-
zona (ARI), California (CAL), Colorado (COL), Indiana (IND), Kansas (KAN), Massachusetts (MAS), Michigan (MIC), New York (NEW), Ohio 
(OHI), South Carolina (SOU), Texas (TEX) of the United States; Christchurch (CHR) and Auckland (AUC) of New Zealand; Canada (CAN); 
Denmark (DEN); England (ENG); Israel (ISR), Lisbon (LIS) of Portugal; Mexico (MEX); Netherland (NET). 
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California and Arizona), several European countries 
(England, Denmark, Portugal, Netherland and Germany), 
and New Zealand. Most of the European patients found 
in the early stage of the pandemic had been to Mexico. 
One patient found in Sichuan Province of China also 
carried the novel influenza virus of the original type. 
The transitional type characterized by 1408T mutation 
was mainly found in New Zealand and Mexico. Se-
quences published after May 12, 2009 showed the type 
that appeared in Thailand, Texas, Michigan and Wiscon-
sin (data not shown). The virus of the New York type 
with both 1408T and 658A mutations mostly appeared in 
North and East of America, such as New York, Massa-
chusetts, Ohio and Canada. The virus of this type also 
appeared in California but the cases were rare in 
GISAID sequence database. The New York type virus 
has been found in New Jersey and Nebraska based on 
the recently released HA sequences (data not shown). To  
summarize, the three groups of novel influenza A(H1N1) 
virus presented distinctive clustering features in their 
geographic distributions (based on the sequencing data 
released before May 20, 2009). The New York type was 
found in North and East of America; the Mexico and 
transitional types mostly appeared in other countries and 
areas.   
The 658A mutation carried by the New York type 
mutated from Serine to Threonine at residue 220 of HA. 
This residue is located in the sialic acid bonding domain 
of HA and close to the important 200-loop region 
(221—228 amino acid)[8]. It has been reported that the 
host of 1918 influenza virus A (H1N1) switched be-
tween humans and avian when the residues at 190 and 
225 sites were mutated[9]. However, there is no solid 
evidence in this study to support the effect of 658A mu-
tation on binding capability of HA and sialic acids. Fur-
ther studies are necessary to address this issue in future. 
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